摘要 |
The disclosure contained herein provides compounds and methods for identification of compounds that agonize or antagonize the function of USP14, a member of the ubiquitin-specific processing protease (UBP) family. Over-expression or gain-of-function of UBP's contributes to a range of diseases such as cancer, thus inhibition of USP14 by antagonists may provide a strategy for therapeutic intervention. Loss-of-function or reduced expression of UBP's, or reduced expression of the proteasome, contributes to improper synaptic activity and neurodegenerative diseases, thus activation of USP14 by agonists may provide a strategy for therapeutic intervention.
|